Logo do repositório
 
Publicação

Pharmacological treatment of COPD : new evidence

dc.contributor.authorPires, N.
dc.contributor.authorPinto, Paula
dc.contributor.authorMarçal, N.
dc.contributor.authorFerreira, A. J.
dc.contributor.authorRodrigues, C.
dc.contributor.authorBárbara, Cristina
dc.date.accessioned2019-09-30T11:44:10Z
dc.date.available2019-09-30T11:44:10Z
dc.date.issued2019
dc.description© 2019 Sociedade Portuguesa de Pneumologia. Published by Elsevier Espana, ˜ S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/bync-nd/4.0/).pt_PT
dc.description.abstractChronic Obstructive Pulmonary Disease (COPD) is currently the 4th leading cause of death worldwide but is projected to be the 3rd leading cause of death by 2020. In Portugal, the estimated prevalence of COPD in the Lisbon region is 14.2%, and a large proportion of underdiagnosed disease has been detected. In 2016, a Portuguese panel of experts proposed pharmacological treatment approaches to COPD based on the evidence available at the time. However, given that the GOLD 2017 report introduced considerable changes to the 2016 version, and that new evidence has emerged regarding treatment options, these proposals need to be updated. Also, and based on several studies, the concept of Pre-GOLD patients, which has diagnostic, prognostic and therapeutic implications, is introduced, along with a proposed algorithm for the identification and treatment of these patients.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationPulmonol. 2019;25(2):90-96pt_PT
dc.identifier.doi10.1016/j.pulmoe.2018.10.005
dc.identifier.issn2531-0429
dc.identifier.urihttp://hdl.handle.net/10451/39643
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherElsevierpt_PT
dc.relation.publisherversionhttps://www.sciencedirect.com/journal/pulmonologypt_PT
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/pt_PT
dc.subjectFLAMEpt_PT
dc.subjectPre-GOLD patientspt_PT
dc.subjectDiagnosispt_PT
dc.subjectAlgorithmpt_PT
dc.titlePharmacological treatment of COPD : new evidencept_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage96pt_PT
oaire.citation.issue2pt_PT
oaire.citation.startPage90pt_PT
oaire.citation.titlePulmonologypt_PT
oaire.citation.volume25pt_PT
person.familyNamePinto
person.familyNameBárbara
person.givenNamePaula Maria Gonçalves
person.givenNameCristina
person.identifier1330713
person.identifier.ciencia-idF01D-6AFB-DFFD
person.identifier.ciencia-id171F-DE21-B23B
person.identifier.orcid0000-0003-2301-2752
person.identifier.orcid0000-0003-0915-4105
person.identifier.scopus-author-id24074744900
person.identifier.scopus-author-id6701574502
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublication51c6d0a2-901f-49cc-b16d-08f96b6a4dd6
relation.isAuthorOfPublicationa16c0cb5-c7f4-4cca-b9f9-bbeb6d35c474
relation.isAuthorOfPublication.latestForDiscoverya16c0cb5-c7f4-4cca-b9f9-bbeb6d35c474

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
COPD_new_evidence.pdf
Tamanho:
677.11 KB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.2 KB
Formato:
Item-specific license agreed upon to submission
Descrição: